Kanagawa, Japan

Yusuke Mochizuki

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Kanagawa, JP (2015 - 2022)
  • Ashigarakami-gun, JP (2019 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Yusuke Mochizuki: Innovator in Transplantation Technology

Introduction

Yusuke Mochizuki is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of transplantation technology, holding a total of 16 patents. His innovative work focuses on developing advanced chambers for transplantation that enhance the viability of biological constituents.

Latest Patents

Mochizuki's latest patents include a chamber for transplantation and a device for transplantation. The first patent describes a planar chamber designed for immunoisolation, featuring membranes that face each other to stably enclose biological constituents. This chamber is engineered to maintain a distance of 10 mm or longer from any joint portion, ensuring flexibility and optimal conditions for the enclosed materials. The second patent elaborates on a chamber that incorporates a porous membrane, which facilitates angiogenesis in recipients while minimizing substance permeability deterioration.

Career Highlights

Yusuke Mochizuki is currently employed at Fujifilm Corporation, where he continues to push the boundaries of transplantation technology. His work has garnered attention for its potential to improve transplant outcomes and enhance patient care.

Collaborations

Mochizuki collaborates with notable colleagues, including Ryuta Takegami and Makoto Sawada. Their combined expertise contributes to the innovative advancements in the field of transplantation.

Conclusion

Yusuke Mochizuki's contributions to transplantation technology exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving the efficacy of biological transplants, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…